Royce & Associates’s Cerence CRNC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q1
Sell
-20,000
Closed -$2.01M 1019
2020
Q4
$2.01M Sell
20,000
-53,000
-73% -$3.95M 0.02% 726
2020
Q3
$3.57M Hold
73,000
0.04% 544
2020
Q2
$2.98M Buy
73,000
+38,847
+114% +$1.12M 0.03% 578
2020
Q1
$526K Buy
34,153
+964
+3% +$20.3K 0.01% 826
2019
Q4
$751K Buy
+33,189
New +$544K 0.01% 842

Other funds holding CRNC

Royce & Associates's CRNC Position: Q1 2021 in Review

Royce & Associates sold out of Cerence (CRNC) in Q1 2021, closing a stake of 20,000 shares — an estimated $2.01M sold.

Royce & Associates first reported a position in CRNC in Q4 2019 and held it in 5 quarters. The position peaked at $3.57M in Q3 2020. 320 funds tracked by Wall St. Rank hold CRNC as of Q1 2021.

  • Royce & Associates reported no remaining Cerence position as of Q1 2021 after selling out during the quarter.
  • Royce & Associates sold 20,000 Cerence shares in Q1 2021, an estimated $2.01M.
  • Royce & Associates first reported a position in Cerence in Q4 2019 and held it in 5 quarters.
  • Royce & Associates's Cerence position peaked at $3.57M in Q3 2020.
  • 320 funds tracked by Wall St. Rank held Cerence as of Q1 2021.

Based on Royce & Associates's 13F filing for Q1 2021, filed 10 May 2021.